Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionIntellectus Partners, LLC
Latest Disclosed Ownership8,947 shares
Latest Disclosed Value $ 1,246,943
Intellectus Partners, LLC ownership in GILD / Gilead Sciences, Inc.

On April 10, 2026 - Intellectus Partners, LLC filed a 13F-HR form disclosing ownership of 8,947 shares of Gilead Sciences, Inc. (US:GILD) valued at $1,246,943 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 10,647 shares of Gilead Sciences, Inc.. This represents a change in shares of -15.97% during the quarter. The current value of the position is $1,154,074 USD.

Intellectus Partners, LLC has a history of taking positions in derivatives of the underlying security (GILD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GILD / Gilead Sciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-10 2026-03-31 13F GILEAD SCIENCES COM 375558103 8,947 -1,700 -15.97 1,247 -4.59 0.2545
2026-02-10 2025-12-31 13F GILEAD SCIENCES COM 375558103 10,647 -257 -2.36 1,307 7.93 0.2525
2025-11-12 2025-09-30 13F GILEAD SCIENCES COM 375558103 10,904 0 0.00 1,210 0.17 0.2345
2025-08-05 2025-06-30 13F GILEAD SCIENCES COM 375558103 10,904 -300 -2.68 1,209 -3.75 0.2610
2025-04-11 2025-03-31 13F GILEAD SCIENCES COM 375558103 11,204 -4,200 -27.27 1,255 -11.74 0.3097
2025-02-07 2024-12-31 13F GILEAD SCIENCES COM 375558103 15,404 -6,025 -28.12 1,423 -20.82 0.3149
2024-11-06 2024-09-30 13F GILEAD SCIENCES COM 375558103 21,429 -19,330 -47.43 1,797 -35.77 0.4592
2024-07-18 2024-06-30 13F GILEAD SCIENCES COM 375558103 40,759 3,721 10.05 2,796 3.06 0.7632
2024-05-03 2024-03-31 13F GILEAD SCIENCES COM 375558103 37,038 7,028 23.42 2,713 11.60 0.7134
2024-02-05 2023-12-31 13F GILEAD SCIENCES COM 375558103 30,010 -4,575 -13.23 2,431 -6.18 0.7016
2023-10-25 2023-09-30 13F GILEAD SCIENCES COM 375558103 34,585 -2,794 -7.47 2,592 -10.03 0.8200
2023-07-31 2023-06-30 13F GILEAD SCIENCES COM 375558103 37,379 -1,533 -3.94 2,881 -10.78 0.8646
2023-05-04 2023-03-31 13F GILEAD SCIENCES COM 375558103 38,912 -33 -0.08 3,229 -3.44 1.0193
2023-02-02 2022-12-31 13F Gilead Sciences Equity 375558103 38,945 -12,016 -23.58 3,343 6.33 1.1639
2022-11-14 2022-09-30 13F Gilead Sciences Equity 375558103 50,961 -37 -0.07 3,144 -0.25 1.1182
2022-08-12 2022-06-30 13F Gilead Sciences Common Stock 375558103 50,998 -413 -0.80 3,152 3.14 1.0830
2022-05-16 2022-03-31 13F Gilead Sciences Common Stock 375558103 51,411 185 0.36 3,056 -17.85 0.9123
2022-02-14 2021-12-31 13F Gilead Sciences Common Stock 375558103 51,226 -170 -0.33 3,720 3.62 0.9483
2021-11-16 2021-09-30 13F Gilead Sciences Equity 375558103 51,396 -1,048 -2.00 3,590 -0.58 0.8689
2021-08-13 2021-06-30 13F Gilead Sciences Equity 375558103 52,444 106 0.20 3,611 6.74 0.8142
2021-05-17 2021-03-31 13F Gilead Sciences Equity 375558103 52,338 17,902 51.99 3,383 68.64 0.9292
2021-02-18 2020-12-31 13F/A-1 Gilead Sciences Common Stock 375558103 34,436 -17,034 -33.10 2,006 -38.31 0.6003
2021-02-12 2020-12-31 13F Gilead Sciences Common Stock 375558103 675 -50,795 2,006 596,443.3423
2020-11-16 2020-09-30 13F Gilead Sciences Common Stock 375558103 51,470 1,440 2.88 3,252 -15.51 1.2288
2020-08-14 2020-06-30 13F Gilead Sciences Equity 375558103 50,030 -445 -0.88 3,849 2.01 1.4919
2020-05-14 2020-03-31 13F Gilead Sciences Equity 375558103 50,475 -8,489 -14.40 3,773 -1.54 1.7978
2020-01-24 2019-12-31 13F Gilead Sciences Common Stock 375558103 58,964 -1,579 -2.61 3,832 -0.13 1.5592
2019-10-10 2019-09-30 13F Gilead Sciences Equity 375558103 60,543 -115 -0.19 3,837 -6.37 1.6864
2019-08-08 2019-06-30 13F Gilead Sciences Common Stock 375558103 60,658 672 1.12 4,098 5.08 1.7732
2019-05-15 2019-03-31 13F Gilead Sciences Equity 375558103 59,986 -15,742 -20.79 3,900 -17.67 1.6776
2019-02-14 2018-12-31 13F Gilead Sciences COM 375558103 75,728 58,080 329.10 4,737 247.54 3.2488
2018-11-15 2018-09-30 13F Gilead Sciences Equity 375558103 17,648 -1,310 -6.91 1,363 1.49 0.4761
2018-08-14 2018-06-30 13F Gilead Sciences Equity 375558103 18,958 736 4.04 1,343 -2.26 0.4899
2018-05-15 2018-03-31 13F Gilead Sciences Equity 375558103 18,222 2,250 14.09 1,374 20.10 0.4720
2018-02-13 2017-12-31 13F Gilead Sciences Equity 375558103 15,972 -866 -5.14 1,144 -16.13 0.4269
2017-11-14 2017-09-30 13F Gilead Sciences Equity 375558103 16,838 -3,620 -17.69 1,364 -5.80 0.5652
2017-08-15 2017-06-30 13F Gilead Sciences Equity 375558103 20,458 2,218 12.16 1,448 16.87 0.6521
2017-05-08 2017-03-31 13F Gilead Sciences Equity 375558103 18,240 2,715 17.49 1,239 11.42 0.6297
2017-02-14 2016-12-31 13F Gilead Sciences Equity 375558103 15,525 15,525 1,112 0.5783
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-05-04 2023-03-31 13F GILEAD SCIENCES Derivative Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-02 2022-12-31 13F GILEAD SCIENCES Derivative Call 19,000 90 n/a n/a n/a
2017-08-15 2017-06-30 13F Call GILD $70.0 Exp Jun 16, 2017 Derivative Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-08 2017-03-31 13F Call GILD $70.0 Exp Jun 16, 2017 Derivative Call 3,500 6 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-05-04 2023-03-31 13F GILEAD SCIENCES Derivative Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-02 2022-12-31 13F GILEAD SCIENCES Derivative Put 10,000 46 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.